Imaging & Diagnostics

Medical researchers at the University of Vienna are investigating whether dual-modality imaging can accurately identify which patients with elevated PSA levels truly require a biopsy. For decades, the standard protocol for suspected prostate cancer has relied heavily on the Prostate-Specific

Severe exertional dyspnea and intestinal obstruction marked the final stages of the patient's seventeen-month battle with this rare and invasive form of urethral malignancy. Primary urethral carcinoma remains one of the most elusive and devastating urological conditions, accounting for less than

The transition from intensity-based to volume-based metabolic assessment represents a significant shift in how oncologists might predict early treatment failure. While traditional staging systems rely heavily on tumor size and lymph node status, they often overlook the metabolic intricacies that

Integrating AI technology into the existing teleradiology workflow allows Krsnaa to maximize the utilization of its capital assets without increasing fixed costs. This strategic partnership with Azmed reflects a broader movement within the healthcare sector to stabilize diagnostic accuracy while

The diagnosis of metastatic medullary thyroid carcinoma is frequently hindered by the high physiological background activity of liver tissue in standard 18F-DOPA scans. This specific challenge is particularly problematic for patients with medullary thyroid carcinoma (MTC), a rare neuroendocrine

Research indicates that the willingness of a radiographer to correct a senior colleague is a prerequisite for maintaining the accuracy and safety of diagnostic procedures. This observation, emphasized in a major 2026 study published in Frontiers in Health Services, highlights a paradigm shift in